← Scroll for more →
Biolife Solutions Inc (BLFS)
Electromedical & Electrotherapeutic Apparatus
Latest Price
$38.85
TTM P/E
33.21
Normalized P/E
--
Div Yield
--
Book Value
8.60
P/B Ratio
4.52
Valuation metrics
adjust assumptions →Base FCF: $8M (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$12.81
67% downside
Institutional Ownership
96.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 6.75M | $190.0M | 13.81% | +244.8K | 2026-06-30 |
| BlackRock, Inc. | 6.38M | $180.0M | 13.04% | +273.8K | 2026-06-30 |
| Casdin Capital, LLC | 4.66M | $131.0M | 9.52% | -1.30M | 2026-06-30 |
| Invesco Ltd. | 2.24M | $63.0M | 4.58% | -108.1K | 2026-06-30 |
| Vanguard Capital Management LLC | 1.96M | $55.0M | 4.02% | +46.4K | 2026-06-30 |
| State Street Corp | 1.66M | $46.0M | 3.39% | +78.9K | 2026-06-30 |
| Geode Capital Management, LLC | 1.09M | $30.0M | 2.22% | +114.9K | 2026-06-30 |
| Massachusetts Financial Services Co | 1.08M | $30.0M | 2.21% | -118.0K | 2026-06-30 |
| Fred Alger Management, LLC | 1.08M | $30.0M | 2.20% | -2.4K | 2026-06-30 |
| Dimensional Fund Advisors LP | 1.05M | $29.0M | 2.14% | +10.5K | 2026-06-30 |